Send us an emailLonza
COMPANY DETAILS
Muenchensteinerstrasse 38
Basel
4002
Switzerland
HEALTH CATEGORIES
Lonza is one of the world’s leading and most-trusted suppliers to the pharmaceutical, biotech and specialty ingredients markets. As an integrated solutions provider, Lonza is boosting its value creation along and beyond the healthcare continuum with a strong focus on patient healthcare, consumer preventive healthcare and consumer's healthy environment.
Lonza harnesses science and technology to create products that support safer and healthier living and that enhance the overall quality of life. With the recent Capsugel acquisition, Lonza now offers products and services from the custom development and manufacturing of active pharmaceutical ingredients to innovative dosage forms for the pharma and consumer health and nutrition industries.
Benefiting from its regulatory expertise, Lonza is able to transfer its know-how from pharma to hygiene and fast-moving consumer goods all the way to coatings and composites and the preservation and protection of agricultural goods and other natural resources.
Founded in 1897 in the Swiss Alps, Lonza today is a well-respected global company with more than 100 sites and offices and approximately 14,500 full-time employees worldwide. The company generated sales of CHF 5.1 billion in 2017 with a CORE EBITDA of CHF 1.3 billion. Further information can be found at www.lonza.com.
Additional Information and Disclaimer
Lonza Group Ltd has its headquarters in Basel, Switzerland, and is listed on the SIX Swiss Exchange. It has a secondary listing on the Singapore Exchange Securities Trading Limited (“SGX-ST”). Lonza Group Ltd is not subject to the SGX-ST’s continuing listing requirements but remains subject to Rules 217 and 751 of the SGX-ST Listing Manual.
Certain matters discussed in this news release may constitute forward-looking statements. These statements are based on current expectations and estimates of Lonza Group Ltd, although Lonza Group Ltd can give no assurance that these expectations and estimates will be achieved. Investors are cautioned that all forward-looking statements involve risks and uncertainty and are qualified in their entirety. The actual results may differ materially in the future from the forward-looking statements included in this news release due to various factors. Furthermore, except as otherwise required by law, Lonza Group Ltd disclaims any intention or obligation to update the statements contained in this news release.
NUTRITION & HEALTH NEWS
12 Jul 2019 --- In nutrition news this week, Lonza expanded the capabilities of its Tampa site with a US$15 million investment, while DSM upgraded its vitamin C facilities in China. DuPont’s... Read More
NUTRITION & HEALTH NEWS
05 Jul 2019 --- In nutrition news this week, Lonza entered into a binding contractual commitment to acquire a sterile drug product fill and finish facility from Novartis, while Fonterra's NZMP... Read More
NUTRITION & HEALTH NEWS
21 Jun 2019 --- In nutrition news this week, the US Food and Drug Administration (FDA) has clarified its Nutrition Facts labels guidance regarding the “Added Sugars” section for... Read More
NUTRITION & HEALTH NEWS
12 Jun 2019 --- A natural superfruit complex, made from orange and pomegranate, can boost physical and mental wellness in active seniors, a recent study has found. The trial demonstrated that... Read More
NUTRITION & HEALTH NEWS
06 Jun 2019 --- Oral supplementation with Peptan collagen peptides may significantly contribute to improving the overall appearance of skin and hair in an ethnically diverse population. This is... Read More
14 May 2019 --- At Vitafoods Europe 2019, Lonza launched its new Vcaps Plus White Opal capsule in a bid to address the growing demand for opaque capsules that do not include titanium dioxide. NutritionInsight spoke with Dominik Mattern, Associate Director Business Development, Head of Business Development, Lonza, about the new launch as well as the company's clean label platform.
25 Apr 2019 --- At In-cosmetics Global 2019 in Paris, Lonza exhibited a number of concepts, including SYNETH, a series of polyglycerol esters. Each fiber offers a unique and innovative texture and aesthetic for the personal, intimate, body and oral care spaces. Jennifer Clancy notes that Lonza is offering turn-key solutions in personal care and beauty and providing consumers with a fully holistic view of health and wellness.
11 Feb 2019 --- Lonza recently revealed the global launch of its latest dosage form innovation: Capsugel Vcaps Plus plant-based capsules. The first of the next-generation clean label solutions to be marketed worldwide is the Vcaps Plus Purple Carrot capsule, following the successful introduction of the Vcaps Plus Blue Spirulina capsule in Europe earlier this year. The high-performance capsule shell is made using plant-based hypromellose (HPMC) and water only, without any preservatives. A colorant derived from purple carrots is used to match the desired shade as closely as possible, while maintaining a natural appearance in the finished supplement. Achieving unique visual appeal, the purple carrot color also provides masking capabilities.
17 Jan 2019 --- Stephane Vouche, of Lonza Capsugel, spoke to NutritionInsight at Health Ingredients Europe (HiE) in 2018 on innovating in ready-to-market formulations. Vouche shared that Lonza was presenting new formulations at the show. One particular innovation included a combination capsule with Lonza's UCT-II ingredient for joint health with curcumin. This combination creates a powerful one-pill solution, meaning consumers do not need to take multiple pills, Vouche said.
22 May 2018 --- Lonza Consumer Health & Nutrition brought innovation through form and function for its latest ingredients, delivery systems and finished product formulations for the nutraceuticals industry to Vitafoods Europe 2018. Visitors could see how innovative ingredients can be combined with cutting-edge dosage forms from the legacy Capsugel business, including DUOCAP capsule-in-capsules and Lipid Multi Particulate (LMP) technology, to create market-ready products positioned on a healthy aging, probiotics or active & sports nutrition platform, among others. In addition, the company highlighted its blue algae Vcaps Plus Spirulina capsule, the next generation of vegetarian food colored capsules, designed to support the development of true clean label solutions.
The aging consumer has growing expectations of bone and joint health solutions, thanks to the mainstreaming of sports nutrition and a growing focus on active aging. According to Innova... Read More
Products featuring bone & joint health claims are on the rise, with Innova Market Insights data showing a compound annual growth rate of 13 percent between 2013 and... Read More
